The Role of Biofilm Infection in Urology

Overview

Journal World J Urol

Specialty Urology

Date 2006 Jan 13

PMID 16402262

Citations 38

Authors

P Tenke

B Kovacs

M Jackel

E Nagy

Affiliations

Soon will be listed here.

Abstract

In the process of endourological development a great variety of foreign bodies have been invented besides urinary catheters on which biofilm can be formed. Bacteria in the biofilm are less sensible to antibiotics. An additional problem of medical biomaterials in the urinary tract environment is the development of encrustation and consecutive obstruction. In this review, we tried to sum up the conditions where biofilm formation has a great impact on the development or maintenance of urological infections and on treatment success. Modification of the biomaterial surface seems to be the most promising prevention strategy for bacterial biofilms. Easier methods for diagnosing and quantifying biofilm infection, to develop more specific antimicrobial agents and ideal device surfaces would surely help the fight against biofilm formation.

Citing Articles

The Role of Butirprost as an Adjuvant in Enhancing the Effect of Antibiotics in Patients Affected by Chronic Bacterial Prostatitis: A Randomized Prospective Trial.

Crocetto F, Calogero A, Santangelo M, Fernicola A, Varlese F, Mirto B Medicina (Kaunas). 2025; 61(1).

PMID: 39859130 PMC: 11767095. DOI: 10.3390/medicina61010148.

Research on a new type of ureteral stent material Zn-2Cu-0.5Fe-xMn with controllable degradation rate.

Zheng J, Zheng Y, Sun P, Zhu D, Fan W, Huang T Heliyon. 2024; 10(17):e37629.

PMID: 39290270 PMC: 11407047. DOI: 10.1016/j.heliyon.2024.e37629.

New insights into the prevention of ureteral stents encrustation.

Guo H, Yuan J Open Med (Wars). 2023; 18(1):20230854.

PMID: 38075034 PMC: 10710215. DOI: 10.1515/med-2023-0854.

AC Electromagnetic Field Controls the Biofilms on the Glass Surface by & Inhibition Effect.

Aoyama N, Kanematsu H, Barry D, Miura H, Ogawa A, Kogo T Materials (Basel). 2023; 16(21).

PMID: 37959648 PMC: 10649311. DOI: 10.3390/ma16217051.

Safe duration of silicon catheter replacement in urological patients.

Oyortey M, Essoun S, Ali M, Abdul-Rahman M, Welbeck J, Dakubo J Ghana Med J. 2023; 57(1):66-74.

PMID: 37576373 PMC: 10416272. DOI: 10.4314/gmj.v57i1.10.

References

Nickel J . Catheter-associated urinary tract infection: new perspectives on old problems. Can J Infect Control. 1991; 6(2):38-42. View

Shigeta M, Komatsuzawa H, Sugai M, Suginaka H, Usui T . Effect of the growth rate of Pseudomonas aeruginosa biofilms on the susceptibility to antimicrobial agents. Chemotherapy. 1997; 43(2):137-41. DOI: 10.1159/000239548. View

Choong S, Wood S, Fry C, Whitfield H . Catheter associated urinary tract infection and encrustation. Int J Antimicrob Agents. 2001; 17(4):305-10. DOI: 10.1016/s0924-8579(00)00348-4. View

Carson C . Infections in genitourinary prostheses. Urol Clin North Am. 1989; 16(1):139-47. View

Habash M, Reid G . Microbial biofilms: their development and significance for medical device-related infections. J Clin Pharmacol. 1999; 39(9):887-98. DOI: 10.1177/00912709922008506. View

Sofer M, Denstedt J . Encrustation of biomaterials in the urinary tract. Curr Opin Urol. 2001; 10(6):563-9. DOI: 10.1097/00042307-200011000-00005. View

Kunin C, Chin Q, Chambers S . Formation of encrustations on indwelling urinary catheters in the elderly: a comparison of different types of catheter materials in "blockers" and "nonblockers". J Urol. 1987; 138(4):899-902. DOI: 10.1016/s0022-5347(17)43412-4. View

Carson 3rd C . Management of prosthesis infections in urologic surgery. Urol Clin North Am. 1999; 26(4):829-39, x. DOI: 10.1016/s0094-0143(05)70223-8. View

Nickel J, Costerton J, McLean R, Olson M . Bacterial biofilms: influence on the pathogenesis, diagnosis and treatment of urinary tract infections. J Antimicrob Chemother. 1994; 33 Suppl A:31-41. DOI: 10.1093/jac/33.suppl_a.31. View

10.

Nickel J, Wright J, Ruseska I, Marrie T, Whitfield C, Costerton J . Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro. Eur J Clin Microbiol. 1985; 4(2):213-8. DOI: 10.1007/BF02013600. View

11.

Reid G . Biofilms in infectious disease and on medical devices. Int J Antimicrob Agents. 1999; 11(3-4):223-6; discussion 237-9. DOI: 10.1016/s0924-8579(99)00020-5. View

12.

Reid G, Potter P, Delaney G, Hsieh J, Nicosia S, Hayes K . Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury. Int J Antimicrob Agents. 2000; 13(4):305-7. DOI: 10.1016/s0924-8579(99)00136-3. View

13.

Reid G, Habash M, Vachon D, Denstedt J, Riddell J, Beheshti M . Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation. Int J Antimicrob Agents. 2001; 17(4):317-9; discussion 319-20. DOI: 10.1016/s0924-8579(00)00353-8. View

14.

Goto T, Nakame Y, Nishida M, Ohi Y . Bacterial biofilms and catheters in experimental urinary tract infection. Int J Antimicrob Agents. 1999; 11(3-4):227-31; discussion 237-9. DOI: 10.1016/s0924-8579(99)00019-9. View

15.

Nickel J, Olson M, McLean R, Grant S, Costerton J . An ecological study of infected urinary stone genesis in an animal model. Br J Urol. 1987; 59(1):21-30. DOI: 10.1111/j.1464-410x.1987.tb04573.x. View

16.

Tsukamoto T, Matsukawa M, Sano M, Takahashi S, Hotta H, Itoh N . Biofilm in complicated urinary tract infection. Int J Antimicrob Agents. 1999; 11(3-4):233-6; discussion 237-9. DOI: 10.1016/s0924-8579(99)00021-7. View

17.

Goto T, Nakame Y, Nishida M, Ohi Y . In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine. Urology. 1999; 53(5):1058-62. DOI: 10.1016/s0090-4295(98)00649-9. View

18.

Costerton J . Introduction to biofilm. Int J Antimicrob Agents. 1999; 11(3-4):217-21; discussion 237-9. DOI: 10.1016/s0924-8579(99)00018-7. View

19.

Tenke P, Riedl C, Jones G, Williams G, Stickler D, Nagy E . Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. Int J Antimicrob Agents. 2004; 23 Suppl 1:S67-74. DOI: 10.1016/j.ijantimicag.2003.12.007. View

20.

Nickel J, Downey J, Costerton J . Movement of pseudomonas aeruginosa along catheter surfaces. A mechanism in pathogenesis of catheter-associated infection. Urology. 1992; 39(1):93-8. DOI: 10.1016/0090-4295(92)90053-y. View